Proteostasis Therapeutics Inc PTI Financial and Strategic SWOT Analysis Review [Report Updated: 11072018] Prices from USD $125

16:46 EDT 11 Aug 2018 | BioPortfolio Report Blog

Proteostasis Therapeutics Inc PTI Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Proteostasis Therapeutics Inc Proteostasis is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company's portfolio spans drug candidates for cystic fibrosis, neurodegeneration and protein conformational diseases. Proteostasis employs Disease Relevant Translation platform that combines proteomics, genomics, and functional assays with medicinal chemistry and systems biology to discover novel drugs for disorders such as Alzheimer's disease, Huntington's disease, and Parkinson's disease. PTI is headquartered in Cambridge, Massachusetts, the US.

Proteostasis Therapeutics Inc Key Recent Developments

Mar 14,2018: Proteostasis Therapeutics Announces Fourth Quarter and YearEnd 2017 Financial Results

Nov 14,2017: Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update

Oct 31,2017: Proteostasis Therapeutics Focuses on Research and Development of CF Drug Candidates and Astellas Pharma Collaboration Programs

Jul 31,2017: Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer

Jul 31,2017: Proteostasis Therapeutics names Helen M. Boudreau as CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Proteostasis Therapeutics Inc PTI Financial and Strategic SWOT Analysis Review [Report Updated: 11072018] Prices from USD $125


More From BioPortfolio on "Proteostasis Therapeutics Inc PTI Financial and Strategic SWOT Analysis Review [Report Updated: 11072018] Prices from USD $125"

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...